PD | 42.3%[50] | Male>female [51] | α-syn pathology affects the circuit that regulates REM sleep, associated with GBA [39], SCARB2 [40], MAPT [40], USP25[40], PINK1 [41], LRRK2 [2] mutations |
MSA | 88%[33] | Female>male [59] | α-syn pathology affects the circuit that regulates REM sleep, depletion of cholinergic neurons in the PPN/LDTN complex, periaqueductal grey matter, and LC [33] |
PSP | 13%[13] | - | Loss of cholinergic neurons in the pedunculopontine tegmentum [13] |
CBD | Case reports[38, 68] | 2 female patients [38, 68] | Degenerative process in cortical and subcortical structures and in the nuclei of the brain stem and pedunculopontine pathways [38]. |
AD | 4.8-26.7%[12, 71] | Male>female [12] | An imbalance of neurotransmitter acetylcholine [12], neuronal loss in LC [12] |
DLB | 46.7-83%[81-83] | Male>female [82] | α-syn pathology affects the circuit that regulates REM sleep [4] |
FTD | Rare (only case report)[90] | 1 male patient [90] | Associated with C9ORF72 repeat expansion [89] |
VaD | 25.6%-72.6%[81, 93] | - | Hypoperfusion or hemodynamic abnormalities affect the brain areas that regulate REM sleep [4] |
HD | 12% or lower[14, 96] | Female>male [14] | Associated with mutant huntingtin [14] |
ALS | 4.9%[15] | 2 male patients [15] | Neurodegeneration of nuclei in REM-associated pathways in the brainstem and the dysfunction of dopaminergic system in substantia nigra striatum may be the main pathophysiological culprit in the development of RBD [15], associated with C9ORF72 repeat expansion [91, 100] |
CJD | 7.1%[101] | 2 male patients [101] | Associated with corticothalamic degeneration [102] |